These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17195356)

  • 21. A glimpse into the history of description of the antiphospholipid syndrome.
    Nour-Eldine W; Noureldine HA; Haydar BA; Eldine MN; Noureldine MHA; Uthman I
    Lupus; 2020 Oct; 29(12):1493-1502. PubMed ID: 32741306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The persistence of anticardiolipin antibodies is associated with an increased risk of the presence of lupus anticoagulant and anti-beta2-glycoprotein I antibodies.
    Neville C; Rauch J; Kassis J; Solymoss S; Joseph L; Belisle P; Subang R; Chang ER; Fortin PR
    Rheumatology (Oxford); 2006 Sep; 45(9):1116-20. PubMed ID: 16510527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I; Levi Y; Godard G; Shoenfeld Y
    Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study.
    Galli M; Borrelli G; Jacobsen EM; Marfisi RM; Finazzi G; Marchioli R; Wisloff F; Marziali S; Morboeuf O; Barbui T
    Blood; 2007 Aug; 110(4):1178-83. PubMed ID: 17440049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification.
    Ruffatti A; Olivieri S; Tonello M; Bortolati M; Bison E; Salvan E; Facchinetti M; Pengo V
    J Thromb Haemost; 2008 Oct; 6(10):1693-6. PubMed ID: 18680541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anticardiolipin antibody and anti-beta 2 glycoprotein I antibody assays.
    Raby A; Moffat K; Crowther M
    Methods Mol Biol; 2013; 992():387-405. PubMed ID: 23546732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of a New Panel of Automated Chemiluminescence Assays for Anticardiolipin Antibodies in the Screening for Antiphospholipid Syndrome.
    Janek D; Slavik L; Ulehlova J; Krcova V; Hlusi A; Prochazkova J
    Clin Lab; 2016 Jul; 62(7):1309-1315. PubMed ID: 28164648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and classification of the antiphospholipid syndrome.
    Gómez-Puerta JA; Cervera R
    J Autoimmun; 2014; 48-49():20-5. PubMed ID: 24461539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of anticardiolipin and anti-beta2-glycoprotein I antibodies.
    Obermoser G; Bitterlich W; Kunz F; Sepp NT
    Int Arch Allergy Immunol; 2004 Oct; 135(2):148-53. PubMed ID: 15345914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. European attempts for the standardisation of the antiphospholipid antibodies.
    Tincani A; Filippini M; Scarsi M; Galli M; Meroni PL
    Lupus; 2009 Sep; 18(10):913-9. PubMed ID: 19671792
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Frequency of antiphospholipid syndrome in women with pregnancy loss in multicenter study in Poland].
    Skrzypczak J; Rajewski M; Wirstlein P; Goździewicz T; Zimmer M; Wołczyński S; Leszczyńska-Gorzelak B; Breborowicz G; Ludwikowski G
    Ginekol Pol; 2011 Oct; 82(10):749-54. PubMed ID: 22379938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome.
    Pengo V; Ruffatti A; Legnani C; Gresele P; Barcellona D; Erba N; Testa S; Marongiu F; Bison E; Denas G; Banzato A; Padayattil Jose S; Iliceto S
    J Thromb Haemost; 2010 Feb; 8(2):237-42. PubMed ID: 19874470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiphospholipid antibodies: evaluation of the thrombotic risk.
    Devreese KM
    Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-Criteria or Seronegative Obstetric Antiphospholipid Syndrome?
    Jara LJ; Medina G; Cruz-Cruz P; Olivares-Rivera J; Duarte-Salazar C; Saavedra MA
    Isr Med Assoc J; 2017 Jun; 19(6):382-386. PubMed ID: 28647939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
    Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
    Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiphospholipid syndrome review.
    Eby C
    Clin Lab Med; 2009 Jun; 29(2):305-19. PubMed ID: 19665680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.